background image

Paid Clinical Trials Tennessee

Discover 1,766 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & ResponsiveNew

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

for
SARS-CoV-2
Location: 10 recruiting locations
Sponsor: ModernaTX, Inc.

Sex: All

Age: 50 - 64

Code: NCT07266558

Recruiting
Active & ResponsiveNew

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

for
Opioid Use Disorder, Opioid Use Disorder, Moderate,
Location: 2 recruiting locations
Sponsor: T. John Winhusen, PhD

Sex: All

Age: 18+

Code: NCT06651177

Phase2, Recruiting
Active & ResponsiveNew

A Study of DII235 in Adults With Elevated Lipoprotein(a)

for
Lipoprotein Disorder
Location: 23 recruiting locations
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07235046

Phase2, Recruiting
Active & Responsive

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: 90 recruiting locations
Sponsor: Cleerly, Inc.

Sex: All

Age: 55+

Code: NCT06112418

Recruiting
Active & Responsive

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: 21 recruiting locations
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT05787587

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of RSLV-132 in Females With Sjögren's Disease

for
Primary Sjögren Syndrome
Location: 23 recruiting locations
Sponsor: Resolve Therapeutics

Sex: Female

Age: 18 - 70+

Code: NCT06440525

Phase2, Recruiting
Active & Responsive

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

for
PIK3CA Mutation, Solid Tumor, Adult,
Location: 19 recruiting locations
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05216432

Phase1, Recruiting
Active & Responsive

Daily Eating Patterns for Total Health Study

for
Obesity
Location: 1 recruiting location
Sponsor: The University of Tennessee, Knoxville

Sex: All

Age: 25 - 60

Code: NCT06455995

Recruiting
Active & Responsive

RESPONDER-HF Trial

for
Heart Failure, Heart Failure, Diastolic
Location: 32 recruiting locations
Sponsor: Corvia Medical

Sex: All

Age: 40+

Code: NCT05425459

Recruiting
Active & Responsive

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

for
Major Depressive Disorder
Location: 36 recruiting locations
Sponsor: Cybin IRL Limited

Sex: All

Age: 18 - 70+

Code: NCT06564818

Phase3, Recruiting

Popular cities in Tennessee

MurfreesboroChattanoogaKnoxvilleNashvilleMemphis